 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/26/2026 |
$1.63 |
$1.66 |
$1.57 |
$1.65 |
767.20K | | 02/27/2026 |
$1.62 |
$1.65 |
$1.59 |
$1.63 |
583.70K | | 03/02/2026 |
$1.57 |
$1.70 |
$1.55 |
$1.66 |
705.70K | | 03/03/2026 |
$1.61 |
$1.71 |
$1.58 |
$1.70 |
1.39M | | 03/04/2026 |
$1.69 |
$1.71 |
$1.63 |
$1.68 |
1.09M |
|
|
| Ovid Therapeutics Inc. is a biopharmaceutical company focused on improving the lives of people with epilepsies and brain conditions with seizure symptoms. It advances a pipeline of novel, targeted small molecule candidates that modulate factors involved in neuronal hyperexcitability. Key developments include OV888 (GV101), a ROCK2 inhibitor for cerebral cavernous malformations; OV329, a GABA-aminotransferase inhibitor for treatment-resistant seizures; and OV350, a KCC2 transporter activator for epilepsies and psychiatric conditions. It also develops soticlestat, a cholesterol 24-hydroxylase inhibitor for Dravet and Lennox-Gastaut syndromes. | |
|
Ovid Therapeutics (OVID) has the following price history information. Looking back at OVID historical stock prices for the last five trading days, on February 26, 2026, OVID opened at $1.63, traded as high as $1.66 and as low as $1.57, and closed at $1.65. Trading volume was a total of 767.20K shares. On February 27, 2026, OVID opened at $1.62, traded as high as $1.65 and as low as $1.59, and closed at $1.63. Trading volume was a total of 583.70K shares. On March 02, 2026, OVID opened at $1.57, traded as high as $1.70 and as low as $1.55, and closed at $1.66. Trading volume was a total of 705.70K shares. On March 03, 2026, OVID opened at $1.61, traded as high as $1.71 and as low as $1.58, and closed at $1.70. Trading volume was a total of 1.39M shares. On March 04, 2026, OVID opened at $1.69, traded as high as $1.71 and as low as $1.63, and closed at $1.68. Trading volume was a total of 1.09M shares.
OVID Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ovid Therapeutics shares, starting with a $10,000 purchase of OVID, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/08/2017 |
|
| End date: |
03/04/2026 |
|
| Start price/share: |
$12.79 |
|
| End price/share: |
$1.68 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-86.86% |
|
| Average Annual Total Return: |
-20.54% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,313.93 |
|
| Years: |
8.83 |
|
|
|
| Date |
Close |
| 02/26/2026 | $1.65 | | 02/27/2026 | $1.63 | | 03/02/2026 | $1.66 | | 03/03/2026 | $1.70 | | 03/04/2026 | $1.68 |
|
|
Free OVID Email Alerts:
